CAS 199113-98-9

Balaglitazone

Description:

Balaglitazone is a synthetic compound belonging to the thiazolidinedione class of drugs, primarily used in the management of type 2 diabetes mellitus. It acts as a selective agonist for the peroxisome proliferator-activated receptor gamma (PPAR-γ), which plays a crucial role in glucose and lipid metabolism. The compound is characterized by its ability to enhance insulin sensitivity, thereby improving glycemic control in diabetic patients. Balaglitazone has been studied for its potential to reduce insulin resistance and promote adipocyte differentiation. Its chemical structure includes a thiazolidinedione moiety, which is essential for its biological activity. The pharmacokinetics of Balaglitazone involve absorption, distribution, metabolism, and excretion processes that are typical for oral antidiabetic agents. While it shows promise in clinical settings, the safety profile and long-term effects of Balaglitazone require thorough evaluation through clinical trials. Overall, Balaglitazone represents a significant advancement in diabetes treatment, focusing on metabolic regulation and insulin action.

Synonyms:

• 2,4-Thiazolidinedione,5-[[4-[(3,4-dihydro-3-methyl-4-oxo-2-quinazolinyl) methoxy]phenyl]methyl]-

2,4-Thiazolidinedione, 5-[[4-[(3,4-dihydro-3-methyl-4-oxo-2-quinazolinyl)methoxy]phenyl]methyl]-

CAS: 199113-98-9

Formula: C₂₀H₁₇N₃O₄S

Purity: 98%

Color and Shape: Solid

Molecular weight: 395.4317

Ref: IN-DA002BWK

Balaglitazone

CAS: 199113-98-9

Balaglitazone

Purity: 99%

Molecular weight: 395.44g/mol

Ref: 54-OR1066075

Balaglitazone

CAS: 199113-98-9

Balaglitazone is a PPARγ agonist that regulates blood glucose and is used in studies of heart failure and myocardial infarction.

Formula: C₂₀H₁₇N₃O₄S

Purity: 99.74%

Color and Shape: Solid

Molecular weight: 395.43

Ref: TM-TQ0272

Balaglitazone

CAS: 199113-98-9

Balaglitazone is an antidiabetic agent classified as a thiazolidinedione, which is a synthetic compound derived from pharmaceutical research focused on insulin sensitization. Its mode of action involves selective activation of the peroxisome proliferator-activated receptor gamma (PPARγ), a nuclear receptor that plays a critical role in adipocyte differentiation and glucose metabolism. By modulating the transcription of specific insulin-responsive genes, Balaglitazone enhances insulin sensitivity in peripheral tissues, thus facilitating more effective glucose uptake and utilization.

Formula: C₂₀H₁₇N₃O₄S

Purity: Min. 95%

Molecular weight: 395.43 g/mol

Ref: 3D-ZHA11398